Arrowstreet Capital’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
2022
Q2
$1.77M Buy
2021
Q4
Sell
2021
Q3
$5.27M Sell
2021
Q2
$13.1M Buy
2020
Q4
Sell
2020
Q3
$525K Buy
2020
Q2
Sell
2020
Q1
$11.1M Buy
2019
Q4
$6.32M Buy